INPT is a patent-pending, breakthrough technology in that there is now no need to catalog or match a person’s infection to an external phage cocktail, a time consuming highly regulated process. New research demonstrates that every human infection enters the body already infected with its own type of phage, in a parasitic/host relationship. Our technology, Induced Native Phage Therapy (INPT) takes control of this relationship regardless the type of infectious agent. Our ongoing research is working to document the ever increasing range of microbes that can be targeted using INPT. The capabilities appear to be endless.
We are the inventor of this technology. What we are doing with native phages has never been done before.